Please do not leave this page until complete. This can take a few moments.
Inside of these downtown Worcester century-old structures, and some contemporary ones, businesses from one of the most cutting-edge industries – technology – have been setting up shop
Webster developer Galaxy Life Sciences purchased the final three lots at The Reactory biomanufacturing campus on Belmont Street in Worcester for $4 million on Thursday.
Waters Corp. in Milford plans to acquire light scattering technology company Wyatt Technology Corp. for $1.36 billion in cash. The deal is expected to close in the second quarter of 2023.
Mercy BioAnalytics, Inc. promoted its chief operating officer, Dawn Mattoon, to the CEO position. Former CEO and Co-founder Paul Blavin transitioned to vice chairman of the board.
Acton-based Insulet, a medical device firm specializing in diabetes treatment, has acquired $25 million in assets from Automated Glucose Control LLC in California.
Acton medical device firm Insulet has acquired $25 million of diabetes pump technology from California-based Bigfoot Biomedical, nearly doubling Insulet’s intellectual property.
Intentsify has appointed tech executive Ajay Subherwal as the company’s new chief revenue officer.
Marlborough biopharma Phio Pharmaceuticals is ushering in a new strategic plan seeking to reposition the company from pure discovery research to full development, utilizing clinical trials.
A Worcester Polytechnic Institute professor of computer science led a team of researchers on a study using artificial intelligence to better predict suicide risk in women.
UMass Chan Medical School in Worcester has licensed its bioinformatics data processing and analysis technology, called Foundry, to Via Scientific Inc., a Cambridge technology company.
When Kathleen Jordan took a job at her university’s advancement office, she could not have predicted it would be the beginning of a decades-long career in fundraising.
Nasuni Corp., a Boston-based cloud storage company with an office in Marlborough, had record revenue in its fiscal 2022, reporting more than $100 million in annual recurring revenue.
Marlborough medical technology company Hologic Inc., reported a decrease in profits of 62.5%, to $187 million, in the first quarter of 2023, which in the same period of the previous year was $499 million.
The annual profits at Boston Scientific, a Marlborough medical device manufacturer, dropped to $698 million in 2022, down from $1.04 billion in 2021.
Watertown-based EyePoint Pharmaceuticals will design and construct a new manufacturing facility in Northbridge focused on development and commercialization of therapeutics for severe eye disorders.
Lawmakers should revive and extend a pandemic-era policy requiring some telehealth services to be reimbursed on par with in-person care, a new state report recommends alongside an in-depth analysis of the remote option's exploding popularity during